TORONTO, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that Conavi Medical Inc. (“Conavi”) will be joining the previously announced Titan Q&A session to be held on Thursday, September 19, 2024 at 5:00 pm ET in connection with the proposed business combination between Titan and Conavi to be considered at the annual general meeting of Titan on September 30, 2024. After the Conavi presentation, Titan will provide prepared remarks followed by a Q&A session. Paul Cataford, Interim President and CEO and Chien Huang, Chief Financial Officer will attend the session on behalf of Titan.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same.
